Effects of the Proteasome Inhibitor Bortezomib in Combination with Chemotherapy for the Treatment of Mantle Cell Lymphoma: A Meta-analysis
Shi-Jun LiJian HaoYu MaoYu-Ling SiPublished in: Turkish journal of haematology : official journal of Turkish Society of Haematology (2019)
MCL patients who are ineligible for transplant or high-dose chemotherapy could benefit from bortezomib-based chemotherapy.